Home » Topics » BioWorld Science

BioWorld Science
RSS

Rodin Therapeutics presents HDAC1 and HDAC2 inhibitors

Aug. 6, 2018

U.S. researchers patent Nampt activators

Aug. 6, 2018

Global collaboration to develop first-in-class gene therapy for cystic fibrosis

Aug. 6, 2018

Potential mechanism of purinergic receptor-mediated remyelination discovered

Aug. 6, 2018

DrugCendR recruiting participants for phase I study of CEND-1 in metastatic pancreatic cancer

Aug. 6, 2018

IL-23 underlies the development of castration-resistant prostate cancer

Aug. 6, 2018

Immatics begins phase I study of IMA-202 in solid tumors

Aug. 6, 2018

Salix enters microbiome collaboration with Cedars-Sinai Medical Center

Aug. 6, 2018

HitGen to identify potential new therapies for tuberculosis and malaria

Aug. 6, 2018

JCR Pharmaceuticals presents data for JR-141 in mucopolysaccharidosis type II

Aug. 6, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
First-in-class non-β-lactam targeting AMR gram-negative pathogens
BioWorld Science
Antimicrobial resistance (AMR) is increasingly compromising the effectiveness of essential antibiotics, resulting in higher global mortality and morbidity rates....